Global Brain Cancer Targeted Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Brain Cancer Targeted Drug market size was valued at USD 1284.1 million in 2023 and is forecast to a readjusted size of USD 2318.1 million by 2030 with a CAGR of 8.8% during review period.

A brain tumor is a mass or growth of abnormal cells in your brain. Many different types of brain tumors exist. 
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Brain Cancer Targeted Drug industry chain, the market status of Hospital (Belzutifan (Welireg), Bevacizumab (Avastin)), Retail Pharmacy (Belzutifan (Welireg), Bevacizumab (Avastin)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Brain Cancer Targeted Drug.

Regionally, the report analyzes the Brain Cancer Targeted Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Brain Cancer Targeted Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Brain Cancer Targeted Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Brain Cancer Targeted Drug industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Belzutifan (Welireg), Bevacizumab (Avastin)).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Brain Cancer Targeted Drug market.

Regional Analysis: The report involves examining the Brain Cancer Targeted Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Brain Cancer Targeted Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Brain Cancer Targeted Drug:
Company Analysis: Report covers individual Brain Cancer Targeted Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Brain Cancer Targeted Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Retail Pharmacy).

Technology Analysis: Report covers specific technologies relevant to Brain Cancer Targeted Drug. It assesses the current state, advancements, and potential future developments in Brain Cancer Targeted Drug areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Brain Cancer Targeted Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Brain Cancer Targeted Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Belzutifan (Welireg)
    Bevacizumab (Avastin)
    Everolimus (Afinitor)

Market segment by Application
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Merck & Co.
    Roche
    Novartis

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Brain Cancer Targeted Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Brain Cancer Targeted Drug, with revenue, gross margin and global market share of Brain Cancer Targeted Drug from 2019 to 2024.
Chapter 3, the Brain Cancer Targeted Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Brain Cancer Targeted Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Brain Cancer Targeted Drug.
Chapter 13, to describe Brain Cancer Targeted Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Brain Cancer Targeted Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Brain Cancer Targeted Drug by Type
        1.3.1 Overview: Global Brain Cancer Targeted Drug Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Brain Cancer Targeted Drug Consumption Value Market Share by Type in 2023
        1.3.3 Belzutifan (Welireg)
        1.3.4 Bevacizumab (Avastin)
        1.3.5 Everolimus (Afinitor)
    1.4 Global Brain Cancer Targeted Drug Market by Application
        1.4.1 Overview: Global Brain Cancer Targeted Drug Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Brain Cancer Targeted Drug Market Size & Forecast
    1.6 Global Brain Cancer Targeted Drug Market Size and Forecast by Region
        1.6.1 Global Brain Cancer Targeted Drug Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Brain Cancer Targeted Drug Market Size by Region, (2019-2030)
        1.6.3 North America Brain Cancer Targeted Drug Market Size and Prospect (2019-2030)
        1.6.4 Europe Brain Cancer Targeted Drug Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Brain Cancer Targeted Drug Market Size and Prospect (2019-2030)
        1.6.6 South America Brain Cancer Targeted Drug Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Brain Cancer Targeted Drug Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Merck & Co.
        2.1.1 Merck & Co. Details
        2.1.2 Merck & Co. Major Business
        2.1.3 Merck & Co. Brain Cancer Targeted Drug Product and Solutions
        2.1.4 Merck & Co. Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Merck & Co. Recent Developments and Future Plans
    2.2 Roche
        2.2.1 Roche Details
        2.2.2 Roche Major Business
        2.2.3 Roche Brain Cancer Targeted Drug Product and Solutions
        2.2.4 Roche Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Roche Recent Developments and Future Plans
    2.3 Novartis
        2.3.1 Novartis Details
        2.3.2 Novartis Major Business
        2.3.3 Novartis Brain Cancer Targeted Drug Product and Solutions
        2.3.4 Novartis Brain Cancer Targeted Drug Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Novartis Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Brain Cancer Targeted Drug Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Brain Cancer Targeted Drug by Company Revenue
        3.2.2 Top 3 Brain Cancer Targeted Drug Players Market Share in 2023
        3.2.3 Top 6 Brain Cancer Targeted Drug Players Market Share in 2023
    3.3 Brain Cancer Targeted Drug Market: Overall Company Footprint Analysis
        3.3.1 Brain Cancer Targeted Drug Market: Region Footprint
        3.3.2 Brain Cancer Targeted Drug Market: Company Product Type Footprint
        3.3.3 Brain Cancer Targeted Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Brain Cancer Targeted Drug Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Brain Cancer Targeted Drug Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Brain Cancer Targeted Drug Consumption Value Market Share by Application (2019-2024)
    5.2 Global Brain Cancer Targeted Drug Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Brain Cancer Targeted Drug Consumption Value by Type (2019-2030)
    6.2 North America Brain Cancer Targeted Drug Consumption Value by Application (2019-2030)
    6.3 North America Brain Cancer Targeted Drug Market Size by Country
        6.3.1 North America Brain Cancer Targeted Drug Consumption Value by Country (2019-2030)
        6.3.2 United States Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        6.3.3 Canada Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        6.3.4 Mexico Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Brain Cancer Targeted Drug Consumption Value by Type (2019-2030)
    7.2 Europe Brain Cancer Targeted Drug Consumption Value by Application (2019-2030)
    7.3 Europe Brain Cancer Targeted Drug Market Size by Country
        7.3.1 Europe Brain Cancer Targeted Drug Consumption Value by Country (2019-2030)
        7.3.2 Germany Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        7.3.3 France Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        7.3.5 Russia Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        7.3.6 Italy Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Brain Cancer Targeted Drug Market Size by Region
        8.3.1 Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Region (2019-2030)
        8.3.2 China Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        8.3.3 Japan Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        8.3.4 South Korea Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        8.3.5 India Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        8.3.7 Australia Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Brain Cancer Targeted Drug Consumption Value by Type (2019-2030)
    9.2 South America Brain Cancer Targeted Drug Consumption Value by Application (2019-2030)
    9.3 South America Brain Cancer Targeted Drug Market Size by Country
        9.3.1 South America Brain Cancer Targeted Drug Consumption Value by Country (2019-2030)
        9.3.2 Brazil Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        9.3.3 Argentina Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Brain Cancer Targeted Drug Market Size by Country
        10.3.1 Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Country (2019-2030)
        10.3.2 Turkey Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)
        10.3.4 UAE Brain Cancer Targeted Drug Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Brain Cancer Targeted Drug Market Drivers
    11.2 Brain Cancer Targeted Drug Market Restraints
    11.3 Brain Cancer Targeted Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Brain Cancer Targeted Drug Industry Chain
    12.2 Brain Cancer Targeted Drug Upstream Analysis
    12.3 Brain Cancer Targeted Drug Midstream Analysis
    12.4 Brain Cancer Targeted Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Brain Cancer Targeted Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Brain Cancer Targeted Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Brain Cancer Targeted Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Brain Cancer Targeted Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Merck & Co. Company Information, Head Office, and Major Competitors
    Table 6. Merck & Co. Major Business
    Table 7. Merck & Co. Brain Cancer Targeted Drug Product and Solutions
    Table 8. Merck & Co. Brain Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Merck & Co. Recent Developments and Future Plans
    Table 10. Roche Company Information, Head Office, and Major Competitors
    Table 11. Roche Major Business
    Table 12. Roche Brain Cancer Targeted Drug Product and Solutions
    Table 13. Roche Brain Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Roche Recent Developments and Future Plans
    Table 15. Novartis Company Information, Head Office, and Major Competitors
    Table 16. Novartis Major Business
    Table 17. Novartis Brain Cancer Targeted Drug Product and Solutions
    Table 18. Novartis Brain Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Novartis Recent Developments and Future Plans
    Table 20. Global Brain Cancer Targeted Drug Revenue (USD Million) by Players (2019-2024)
    Table 21. Global Brain Cancer Targeted Drug Revenue Share by Players (2019-2024)
    Table 22. Breakdown of Brain Cancer Targeted Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 23. Market Position of Players in Brain Cancer Targeted Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 24. Head Office of Key Brain Cancer Targeted Drug Players
    Table 25. Brain Cancer Targeted Drug Market: Company Product Type Footprint
    Table 26. Brain Cancer Targeted Drug Market: Company Product Application Footprint
    Table 27. Brain Cancer Targeted Drug New Market Entrants and Barriers to Market Entry
    Table 28. Brain Cancer Targeted Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 29. Global Brain Cancer Targeted Drug Consumption Value (USD Million) by Type (2019-2024)
    Table 30. Global Brain Cancer Targeted Drug Consumption Value Share by Type (2019-2024)
    Table 31. Global Brain Cancer Targeted Drug Consumption Value Forecast by Type (2025-2030)
    Table 32. Global Brain Cancer Targeted Drug Consumption Value by Application (2019-2024)
    Table 33. Global Brain Cancer Targeted Drug Consumption Value Forecast by Application (2025-2030)
    Table 34. North America Brain Cancer Targeted Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 35. North America Brain Cancer Targeted Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 36. North America Brain Cancer Targeted Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 37. North America Brain Cancer Targeted Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 38. North America Brain Cancer Targeted Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 39. North America Brain Cancer Targeted Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 40. Europe Brain Cancer Targeted Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 41. Europe Brain Cancer Targeted Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 42. Europe Brain Cancer Targeted Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 43. Europe Brain Cancer Targeted Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 44. Europe Brain Cancer Targeted Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 45. Europe Brain Cancer Targeted Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 46. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 47. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 48. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 49. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 50. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Region (2019-2024) & (USD Million)
    Table 51. Asia-Pacific Brain Cancer Targeted Drug Consumption Value by Region (2025-2030) & (USD Million)
    Table 52. South America Brain Cancer Targeted Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 53. South America Brain Cancer Targeted Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 54. South America Brain Cancer Targeted Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 55. South America Brain Cancer Targeted Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 56. South America Brain Cancer Targeted Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 57. South America Brain Cancer Targeted Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 58. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Type (2019-2024) & (USD Million)
    Table 59. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Type (2025-2030) & (USD Million)
    Table 60. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Application (2019-2024) & (USD Million)
    Table 61. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Application (2025-2030) & (USD Million)
    Table 62. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Country (2019-2024) & (USD Million)
    Table 63. Middle East & Africa Brain Cancer Targeted Drug Consumption Value by Country (2025-2030) & (USD Million)
    Table 64. Brain Cancer Targeted Drug Raw Material
    Table 65. Key Suppliers of Brain Cancer Targeted Drug Raw Materials
List of Figures
    Figure 1. Brain Cancer Targeted Drug Picture
    Figure 2. Global Brain Cancer Targeted Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Brain Cancer Targeted Drug Consumption Value Market Share by Type in 2023
    Figure 4. Belzutifan (Welireg)
    Figure 5. Bevacizumab (Avastin)
    Figure 6. Everolimus (Afinitor)
    Figure 7. Global Brain Cancer Targeted Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 8. Brain Cancer Targeted Drug Consumption Value Market Share by Application in 2023
    Figure 9. Hospital Picture
    Figure 10. Retail Pharmacy Picture
    Figure 11. Other Picture
    Figure 12. Global Brain Cancer Targeted Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 13. Global Brain Cancer Targeted Drug Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 14. Global Market Brain Cancer Targeted Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 15. Global Brain Cancer Targeted Drug Consumption Value Market Share by Region (2019-2030)
    Figure 16. Global Brain Cancer Targeted Drug Consumption Value Market Share by Region in 2023
    Figure 17. North America Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 18. Europe Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 19. Asia-Pacific Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 20. South America Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 21. Middle East and Africa Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 22. Global Brain Cancer Targeted Drug Revenue Share by Players in 2023
    Figure 23. Brain Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 24. Global Top 3 Players Brain Cancer Targeted Drug Market Share in 2023
    Figure 25. Global Top 6 Players Brain Cancer Targeted Drug Market Share in 2023
    Figure 26. Global Brain Cancer Targeted Drug Consumption Value Share by Type (2019-2024)
    Figure 27. Global Brain Cancer Targeted Drug Market Share Forecast by Type (2025-2030)
    Figure 28. Global Brain Cancer Targeted Drug Consumption Value Share by Application (2019-2024)
    Figure 29. Global Brain Cancer Targeted Drug Market Share Forecast by Application (2025-2030)
    Figure 30. North America Brain Cancer Targeted Drug Consumption Value Market Share by Type (2019-2030)
    Figure 31. North America Brain Cancer Targeted Drug Consumption Value Market Share by Application (2019-2030)
    Figure 32. North America Brain Cancer Targeted Drug Consumption Value Market Share by Country (2019-2030)
    Figure 33. United States Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 34. Canada Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 35. Mexico Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 36. Europe Brain Cancer Targeted Drug Consumption Value Market Share by Type (2019-2030)
    Figure 37. Europe Brain Cancer Targeted Drug Consumption Value Market Share by Application (2019-2030)
    Figure 38. Europe Brain Cancer Targeted Drug Consumption Value Market Share by Country (2019-2030)
    Figure 39. Germany Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 40. France Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 41. United Kingdom Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 42. Russia Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 43. Italy Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 44. Asia-Pacific Brain Cancer Targeted Drug Consumption Value Market Share by Type (2019-2030)
    Figure 45. Asia-Pacific Brain Cancer Targeted Drug Consumption Value Market Share by Application (2019-2030)
    Figure 46. Asia-Pacific Brain Cancer Targeted Drug Consumption Value Market Share by Region (2019-2030)
    Figure 47. China Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 48. Japan Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 49. South Korea Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 50. India Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 51. Southeast Asia Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 52. Australia Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 53. South America Brain Cancer Targeted Drug Consumption Value Market Share by Type (2019-2030)
    Figure 54. South America Brain Cancer Targeted Drug Consumption Value Market Share by Application (2019-2030)
    Figure 55. South America Brain Cancer Targeted Drug Consumption Value Market Share by Country (2019-2030)
    Figure 56. Brazil Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 57. Argentina Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 58. Middle East and Africa Brain Cancer Targeted Drug Consumption Value Market Share by Type (2019-2030)
    Figure 59. Middle East and Africa Brain Cancer Targeted Drug Consumption Value Market Share by Application (2019-2030)
    Figure 60. Middle East and Africa Brain Cancer Targeted Drug Consumption Value Market Share by Country (2019-2030)
    Figure 61. Turkey Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 62. Saudi Arabia Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 63. UAE Brain Cancer Targeted Drug Consumption Value (2019-2030) & (USD Million)
    Figure 64. Brain Cancer Targeted Drug Market Drivers
    Figure 65. Brain Cancer Targeted Drug Market Restraints
    Figure 66. Brain Cancer Targeted Drug Market Trends
    Figure 67. Porters Five Forces Analysis
    Figure 68. Manufacturing Cost Structure Analysis of Brain Cancer Targeted Drug in 2023
    Figure 69. Manufacturing Process Analysis of Brain Cancer Targeted Drug
    Figure 70. Brain Cancer Targeted Drug Industrial Chain
    Figure 71. Methodology
    Figure 72. Research Process and Data Source

Companies Mentioned

Merck & Co.
Roche
Novartis